Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,215 | 18,780 | 23,899 | 37,870 | 65,064 |
| Marketable Securities | 114,980 | 130,887 | 130,964 | 122,084 | 79,738 |
| Receivables | 17,839 | 15,395 | 9,488 | 4,865 | 7,487 |
| Inventories | 3,258 | 3,909 | 3,640 | 5,312 | 3,666 |
| Other current assets | 0 | 0 | 0 | 368 | 2,382 |
| TOTAL | $181,186 | $177,854 | $177,648 | $180,474 | $166,401 |
| Non-Current Assets | |||||
| PPE Net | 3,320 | 3,186 | 3,104 | 3,100 | 2,616 |
| Intangibles | 41,328 | 44,642 | 47,878 | 56,966 | 34,316 |
| Other Non-Current Assets | 19,648 | 22,303 | 21,076 | 14,470 | 11,748 |
| TOTAL | $64,296 | $70,131 | $72,058 | $74,536 | $48,680 |
| Total Assets | $245,482 | $247,985 | $249,706 | $255,010 | $215,081 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 268 | 286 | 283 | 454 | 434 |
| Accounts payable and accrued liabilities | 7,105 | 8,966 | 7,043 | 17,674 | 5,048 |
| Accrued Expenses | 17,222 | 13,032 | 10,592 | 3,346 | 9,308 |
| Other current liabilities | 34,403 | 33,786 | 30,164 | 29,014 | 25,337 |
| TOTAL | $62,421 | $59,185 | $58,188 | $60,943 | $45,248 |
| Non-Current Liabilities | |||||
| Long Term Debt | 547 | 734 | 788 | 710 | 684 |
| Deferred Revenues | 2,223 | 3,115 | 3,820 | 4,611 | 5,121 |
| Other Non-Current Liabilities | 140,445 | 151,233 | 138,892 | 120,151 | 100,015 |
| TOTAL | $140,992 | $151,967 | $139,680 | $124,368 | $100,699 |
| Total Liabilities | $203,413 | $211,152 | $197,868 | $185,311 | $145,947 |
| Shareholders' Equity | |||||
| Common Shares | 414 | 6,331 | 6,331 | 6,331 | 6,331 |
| Retained earnings | -319,800 | -324,534 | -304,540 | -286,169 | -278,524 |
| Other shareholders' equity | -23,565 | -19,688 | -18,850 | -16,922 | -22,657 |
| TOTAL | $42,069 | $36,833 | $51,838 | $69,699 | $69,134 |
| Total Liabilities And Equity | $245,482 | $247,985 | $249,706 | $255,010 | $215,081 |